Term ended Apr 12, 2026 · High confidence
20-year base term ended Apr 12, 2026
Held by Roche Diabetes Care, Inc.
Filed Nov 14, 2023 as application 18/508,936 · Granted Dec 2, 2025
Base term, 20 years from filing
Today
Term ended Apr 12, 2026
2006
2026
Clock starts
Apr 12, 2006
Apr 12, 2006
Term ended
Apr 12, 2026
Apr 12, 2026
Granted
Dec 2, 2025
Dec 2, 2025
base term
after the term ends
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 10,803,989, US 11,593,081, US 9,811,633, to Apr 12, 2026. The term already ends on or before that date, so the cap shortened nothing.
None due
Maintenance fees
This term ends before the first maintenance fee's grace period does, 4 years from grant, so no fee can end it early.
8
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Apr 12, 2006, when application PCT/EP2006/061554, the earliest non-provisional in its chain, was filed (this one was filed Nov 14, 2023) | Apr 12, 2026 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 10,803,989, US 11,593,081, US 9,811,633) | resolves to Apr 12, 2026, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | No maintenance fee can end the term early | term ended | High confidence |
| Computed term end | The steps above, in order | Apr 12, 2026 | High confidence |
This family
| US 9,811,633 | In force Apr 2031 | Apr 2031 |
| US 10,803,989 | Term ended Nov 2026 | Nov 2026 |
| Application 17/038,823 | Abandoned not computed | not computed |
| US 11,494,172 | Term ended Apr 2026 | Apr 2026 |
| US 11,593,081 | Term ended Apr 2026 | Apr 2026 |
| Application 18/360,647 | Abandoned not computed | not computed |
| US 12,487,806 | this patent Apr 2026 | Apr 2026 |
7 of 8 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jul 7, 2025 Reel 71617, frame 590 | Cronrath, Christoph; Andreu, Fernando; Val Vicente, Alberto | Roche Diagnostics GmbH | Assignment of Assignor's Interest |
| Jul 7, 2025 Reel 71617, frame 721 | Roche Diagnostics GmbH | Roche Diagnostics Operations, Inc. | Assignment of Assignor's Interest |
| Jul 7, 2025 Reel 71819, frame 675 | Roche Diagnostics Operations, Inc. | Roche Diabetes Care, Inc. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
Terminal disclaimer
A terminal disclaimer resolved from the filed document, referencing US 10,803,989, US 11,593,081, US 9,811,633, ends no earlier than this term, so it caps nothing.
Citations
0
later US patents cite this one
Fewer than half of the utility patents granted in 2025 in our data have been cited yet, so we show the count and do not rank on it.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.